Trial Details

COMPLETED
Basic Information
Clinical ID c4483
Identifier NCT00449722
Trial Title OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: mesalazine
Participant Information
Sponsor Dr. Falk Pharma GmbH
City Cologne
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2005-07
Primary Completion Date -
Completion Date 2006-06